SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-21-000029
Filing Date
2021-12-16
Accepted
2021-12-16 19:03:12
Documents
3
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163969937662511.html 4  
1 FORM 4 wf-form4_163969937662511.xml 4 5818
2 211216 PD POA a211215_pdxskyexbiox-xpo.htm EX-24 3704
3 211216 PD POA a211215_pdxskyexbiox-xpo001.jpg GRAPHIC 246905
  Complete submission text file 0001516551-21-000029.txt   351349
Mailing Address 5820 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
DHILLON PUNIT (Reporting) CIK: 0001425052 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55136 | Film No.: 211499146

Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations